Status of group B streptococcal vaccine development
Open Access
- 1 January 2018
- journal article
- research article
- Published by XMLink in Clinical and Experimental Vaccine Research
- Vol. 7 (1) , 76-81
Abstract
Lin SM, et al. Clin Exp Vaccine Res. 2018 Jan;7(1):76-81. https://doi.org/10.7774/cevr.2018.7.1.76Keywords
Funding Information
- National Research Foundation of Korea (NRF-2017M2A2A6A02020925)
- Ministry of Science, ICT and Future Planning
This publication has 57 references indexed in Scilit:
- Development of a Fourfold Multiplexed Opsonophagocytosis Assay for Pneumococcal Antibodies against Additional Serotypes and Discovery of Serological Subtypes in Streptococcus pneumoniae Serotype 20Clinical and Vaccine Immunology, 2012
- Structure-based approach to rationally design a chimeric protein for an effective vaccine against Group B Streptococcus infectionsProceedings of the National Academy of Sciences, 2011
- Surfome Analysis as a Fast Track to Vaccine DiscoveryMolecular & Cellular Proteomics, 2009
- Group BStreptococcusPullulanase Crystal Structures in the Context of a Novel Strategy for Vaccine DevelopmentJournal of Bacteriology, 2009
- Serotype IX, a Proposed New Streptococcus agalactiae SerotypeJournal of Clinical Microbiology, 2007
- Group B Streptococcus: global incidence and vaccine developmentNature Reviews Microbiology, 2006
- Development and Validation of a Fourfold Multiplexed Opsonization Assay (MOPA4) for Pneumococcal AntibodiesClinical and Vaccine Immunology, 2006
- Molecular Characterization of Nontypeable Group B StreptococcusJournal of Clinical Microbiology, 2006
- Group B beta hemolytic streptococcal meningitis in infantsThe Journal of Pediatrics, 1973
- Group B streptococcal neonatal and infant infectionsThe Journal of Pediatrics, 1973